Featured Archives - Market Exclusive

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Featured

Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Ackman and the Nature of Impermanence

Looking Ahead To The Potentially Game Changing TESARO Inc (NASDAQ:TSRO) Data

Here’s What Happened With Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Tenax Therapeutics Inc (NASDAQ:TENX)

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Update Reinforces Cystic Fibrosis Dominance

Who Would Make a Good Suitor for Shield Therapeutics?

Two Of This Week’s Movers And Shakers In Biotech

Here’s What The FDA Knock Back Means For Incyte Corporation (NASDAQ:INCY)...

A Look At Puma Biotechnology Inc (NYSE:PBYI)’s Breast Cancer Candidate

Here’s What Just Happened With AstraZeneca plc (ADR) (NYSE:AZN), TESARO Inc...

Here’s Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A...

What Is the Real Cost of AstraZeneca’s Eye Cancer Flop?

What’s In The Latest Heron Therapeutics Inc (NASDAQ:HRTX) Data?

Biotech Movers: EnteroMedics Inc (NASDAQ:ETRM) and Stemline Therapeutics Inc (NASDAQ:STML)

Here’s a Look at the Current CDK Inhibition Landscape

Oramed is about to Revolutionize Diabetes Treatment

EDITOR PICKS

Here’s What’s Moving Novartis AG (ADR) (NYSE:NVS) and Kamada Ltd (NASDAQ:KMDA)

Here’s What Just Happened With Cara Therapeutics, Inc. (NASDAQ:CARA) and ImmunoCellular...

Biotech Movers: Egalet Corporation (NASDAQ:EGLT) and Neos Therapeutics, Inc. (NASDAQ:NEOS)

POPULAR POSTS

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

POPULAR CATEGORY